Issue Special Issue 1/2007
VII Madrid Breast Cancer Conference: Changes in the treatment of breast cancer
Content (47 Articles)
Assessing prognosis for early breast cancer: clinical versus genetic profiles
GN Hortobagyi
Circulating tumor cells as predictors of recurrence in primary breast cancer
W Janni
Circulating tumor and endothelial cells as predictors of response in metastatic breast cancer
M Cristofanilli
Molecular and gene expression-based predictors of response to preoperative chemotherapy
L Pusztai
Surgical issues in the breast and axillary nodes in patients treated with neoadjuvant systemic therapy
EP Mamounas
Treatment of the intact primary in women with metastatic breast cancer
SA Khan, H Hazard, D Scholtens
The nipple sparing mastectomy: a 5-year experience at the European Institute of Oncology of Milan
JY Petit, U Veronesi, R Orecchia, A Luini
Current status of adjuvant endocrine therapy for premenopausal patients with primary breast cancer
A Howell
Treatment of metastatic disease after current adjuvant approaches (taxanes, aromatase inhibitors, trastuzumab)
PF Conte, V Guarneri, C Bengala
Standards and future strategies in adjuvant chemotherapy treatments
C Hudis, H McArthur
Preoperative systemic treatment for operable disease: biological correlates of response to neoadjuvant treatment
GN Hortobagyi
Prognostic factors for the node-negative breast cancers
B-W Park, J-H Kim, K-S Kim, KS Lee
Retreatment with trastuzumab in Her2-positive metastatic breast cancer patients: a clinical study
F Carabantes-Ocón, E Saez-Lara, L Burgos-Garcia, E Villar-Chamorro, A Casaus-Hazañas, S Luna, C Martínez
Do breast cancer tumours downsize as well as downgrade with neoadjuvant chemotherapy?
M Dani, J McDonnell, S Karp, V Jaffe
Saline instillation into the cavity after conservation surgery for breast cancer is a safe way of improving cosmesis
M Dani, T Tahmid, J McDonnell, V Jaffe
A safety and efficacy study of bleomycin sulfate and electroporation in patients with metastatic or locally recurrent breast cancer
V Paramanov, O Tyurin, S Polenkov, PM Goldfarb
Predictive value of HER2 expression for the selection of adjuvant chemotherapy in breast cancer patients
A Hegmane, U Vikmanis
Axillary study before surgery in patients with breast cancer
M Izquierdo, R Fabregas, J Feu, L Lopez Marin, B Navarro, C Ara, M Cusido, F Tresserra
Partial breast irradiation with an electron beam for patients submitted to conservative surgery
MAC Maia, MM Netto, MS Maciel, JC Donoso, JV Salvajoli, ACA Pellizzon, RC Fogaroli, KW Bocalletti, C Tanous
Positive axillary lymph node metastases in T1–T3 breast cancer: prognostic value of extracapsular extension
S Maksimovic, Z Gojkovic, M Opric
Study of the combination gemcitabine and trastuzumab in the treatment of HER2+ metastatic breast cancer
S Menjón-Beltrán, R Olivencia-Dueso, E González-Jiménez, MJ Titos
Clinical role of trastuzumab in metastatic breast cancer: experience of a center
S Menjón-Beltrán, R Olivencia, E Gonzalez
BRCA1a has antitumor activity in triple-negative breast cancers
C Yuli, N Shao, G Oprea-llies, J Okoli, ESP Reddy, VN Rao
Diagnosis of familial breast cancer by multiplex PCR and clinical parameters
H Rassi
Novel method of sentinel lymph node detection in malignant tumors using preparation 'UNIMAG'
B Surguladze, R Zhorzoliani, T Tskitishvili
Frequency of febrile neutropenia in patients treated with taxane/epirubicine and colony-stimulating growth factors for breast cancer: comparison of filgrastim/lenograstim with pegfilgrastim
W Schippinger, R Holub, N Dandachi, T Bauernhofer
Comparison of side-effect profiles during active treatment versus follow-up in the International Breast Cancer Intervention Study I tamoxifen prevention trial
I Sestak, R Edwards, A Howell, J Cuzick
Minimal residue disease (MRD)
A Zaidi, G Tripuraneni, S Weller, B Ward, HD Sinnett, RC Coombes, MJ Slade
Algorithm for identification of individuals with hereditary predisposition to breast cancer and other breast cancer-associated forms of malignant neoplasms
IV Zalutsky, NN Antonenkova, GM Porubova
Identification of individuals with hereditary predisposition to breast cancer and other breast cancer-associated forms of malignant neoplasms: data of the Belarusian Cancer Registry
IV Zalutsky, NN Antonenkova
Tachosil® to reduce the morbidity of axillary lymph node dissection in breast cancer
E Barranger, O Morel, G Akerman, C Malartic, D Clement
First clinical results on the potential of intraoperative imaging for sentinel lymph node biopsy in breast cancer
E Barranger, K Kerrou, S Pitre, MA Duval, C Coutant, R Siebert, J Talbot, Y Charon, S Uzan
Preliminary safety data of preoperative chemotherapy plus trastuzumab, lapatinib or both in HER2-positive operable breast cancer
V Guarneri, A Frassoldati, F Piacentini, K Cagossi, L Cavanna, A Michelotti, G Jovic, S Giovannelli, G Ficarra, C Oliva, P Conte
Significance of nuclear medicine: 99mTc-MDP in the detection of breast cancer bone metastasis
P Karan, AN Tiwari, R Pisal